A study conducted by Tanaka et al. showed that the PDT with talaporfin and co-treatment with PARP-1 inhibitors, such as Olaparib, enhanced the efficacy of PDT in gastric cancer cells (MKN45) examined by DSB induction [25,39]. The gene discussed is PARP1; the disease is gastric cancer.